
|Articles|March 1, 1997
The American Journal of Managed Care
- March 1997
- Volume 3
- Issue 3
A Cost/Efficacy Analysis of Oral Antifungals Indicated for the Treatment of Onychomycosis: Griseofulvin, Itraconazole, and Terbinafine
Advertisement
Articles in this issue
almost 29 years ago
The Political Economy of Capitated Managed Carealmost 29 years ago
Appropriate and Necessary Healthcare: New Language for a New Eraalmost 29 years ago
Managing Asthma CareNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
In CLL, New Therapies Offer Potential for Personalized Approaches
4
ICYMI: Highlights From CROI 2025
5










































